GSL Securities (BSE 530469)₹64.680.00%Non Banking Financial Company (NBFC)
At the end of the Jun 2026 quarter, GSL Securities' shareholders were: promoters 44.60%, public 55.40%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 3,824 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 40.90% | 40.90% | 40.90% | 40.90% | 40.90% | 40.90% | 40.90% | 40.90% | 40.90% | 44.60% | 44.60% | 44.60% |
| Public | 59.10% | 59.10% | 59.10% | 59.10% | 59.10% | 59.10% | 59.10% | 59.10% | 59.10% | 55.40% | 55.40% | 55.40% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 3,799 | 3,811 | 3,798 | 3,800 | 3,904 | 4,035 | 4,035 | 3,978 | 3,900 | 3,882 | 3,861 | 3,824 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Shailja Bagrodia | Promoter | 9.43% | 0.00 |
| Sant Kumar Bagrodia | Promoter | 8.28% | 0.00 |
| Shrikant Bhangdiya | Public | 8.00% | 0.00 |
| Aarti Bhangdiya | Public | 7.98% | 0.00 |
| Sonal Kirtikumar Bhangdiya | Public | 7.96% | 0.00 |
| Mangalam Exim Private Limited | Promoter | 7.77% | 0.00 |
| Nalini Stock Brokers Private | Promoter | 7.46% | 0.00 |
| Kumaar Bagrodia | Promoter | 5.89% | 0.00 |
| Shree Kumar Mangalam Traders Private Limited | Promoter | 5.74% | 0.00 |
| F3 Advisors Private Limited | Public | 1.07% | −0.01 |
| Sandeep Goenka | Promoter | 0.01% | 0.00 |
| Archana Goenka | Promoter | 0.00% | 0.00 |
Promoters held 44.60% of GSL Securities at the end of the Jun 2026 quarter, up 3.70 percentage points from 40.90% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
GSL Securities had 3,824 shareholders at the end of the Jun 2026 quarter, against 3,978 a year earlier.
Shrikant Bhangdiya (Public) held 8.00% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.